These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 9876563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhancement of dissolution and bioavailability of flurbiprofen by low molecular weight chitosans.
    Anraku M, Arahira M, Mady FM, Khaled KA, Yamasaki K, Seo H, Imai T, Otagiri M.
    Pharmazie; 2010 Jul; 65(7):461-6. PubMed ID: 20662311
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of rapeseed phospholipids on ibuprofen dissolution from solid dispersions.
    Sosada M, Gorecki M, Pasker B.
    Pharmazie; 2006 Aug; 61(8):677-80. PubMed ID: 16964709
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S, Ortega M, Ma C.
    Int J Pharm; 2005 Sep 14; 301(1-2):209-16. PubMed ID: 16046087
    [Abstract] [Full Text] [Related]

  • 9. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil.
    Charoo NA, Shamsher AA, Kohli K, Pillai K, Rahman Z.
    Colloids Surf B Biointerfaces; 2008 Sep 01; 65(2):300-7. PubMed ID: 18579348
    [Abstract] [Full Text] [Related]

  • 10. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen.
    Daravath B, Tadikonda RR, Vemula SK.
    Drug Dev Ind Pharm; 2015 Sep 01; 41(8):1254-62. PubMed ID: 25039470
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of the oral dissolution time on the absorption rate of locally administered solid formulations for oromucosal use: the flurbiprofen lozenges paradigm.
    Imberti R, De Gregori S, Lisi L, Navarra P.
    Pharmacology; 2014 Sep 01; 94(3-4):143-7. PubMed ID: 25277061
    [Abstract] [Full Text] [Related]

  • 14. Solvent change co-precipitation with hydroxypropyl methylcellulose phthalate to improve dissolution characteristics of a poorly water-soluble drug.
    Sertsou G, Butler J, Hempenstall J, Rades T.
    J Pharm Pharmacol; 2002 Aug 01; 54(8):1041-7. PubMed ID: 12195817
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preparation of a solid dispersion of felodipine using a solvent wetting method.
    Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK.
    Eur J Pharm Biopharm; 2006 Oct 01; 64(2):200-5. PubMed ID: 16750355
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the bioavailability of flurbiprofen and its beta-cyclodextrin inclusion complex in four different doses upon oral administration to rats.
    Muraoka A, Tokumura T, Machida Y.
    Eur J Pharm Biopharm; 2004 Nov 01; 58(3):667-71. PubMed ID: 15451543
    [Abstract] [Full Text] [Related]

  • 20. A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation.
    Li S, Wang X, Wang Y, Zhao Q, Zhang L, Yang X, Liu D, Pan W.
    Drug Dev Ind Pharm; 2015 Nov 01; 41(12):2089-99. PubMed ID: 26304493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.